Strategic MOU to Advance AI-Powered Cardiac Imaging
๐ Overview Phantomics Inc., a deep-tech startup in medical imaging AI, has signed an MOU with Severance Cardiovascular Hospital, Korea’s top-tier heart care center. This partnership aims to accelerate clinical adoption and global validation of Phantomics’ flagship solutions:
Myomics®: AI-powered cardiac MRI analysis
Angiomics®: AI solution for coronary CT analysis
๐ Key Objectives
Co-develop AI algorithms using real-world hospital data
Improve early diagnosis of heart failure, myocarditis, amyloidosis & more
Validate and expand clinical applications across Asia and beyond
Hold joint academic forums and publish collaborative research
๐ก Why It Matters
Faster diagnosis, better accuracy: 95%+ precision with AI-driven insights
Global traction: Deployed in 20+ Korean hospitals and expanding across Japan, Taiwan, Singapore, Thailand, Europe — and soon, North America
Proven innovation: CES Innovation Award & FIX Best Innovation Winner
Severance strength: World-class hospital ranked by Newsweek, with 30,000+ ablation procedures and deep clinical expertise
๐ฃ๏ธ Leadership Quotes
“This partnership will strengthen the clinical value of AI in cardiac care and help save lives.” – Panki Kim, Co-CEO, Phantomics “We’re excited to combine our clinical depth with Phantomics' technology to improve early detection and outcomes.” – Dr. Seok Min Kang, Director, Severance Cardiovascular Hospital
Strategic MOU to Advance AI-Powered Cardiac Imaging
๐ Overview
Phantomics Inc., a deep-tech startup in medical imaging AI, has signed an MOU with Severance Cardiovascular Hospital, Korea’s top-tier heart care center. This partnership aims to accelerate clinical adoption and global validation of Phantomics’ flagship solutions:
Myomics®: AI-powered cardiac MRI analysis
Angiomics®: AI solution for coronary CT analysis
๐ Key Objectives
Co-develop AI algorithms using real-world hospital data
Improve early diagnosis of heart failure, myocarditis, amyloidosis & more
Validate and expand clinical applications across Asia and beyond
Hold joint academic forums and publish collaborative research
๐ก Why It Matters
Faster diagnosis, better accuracy: 95%+ precision with AI-driven insights
Global traction: Deployed in 20+ Korean hospitals and expanding across Japan, Taiwan, Singapore, Thailand, Europe — and soon, North America
Proven innovation: CES Innovation Award & FIX Best Innovation Winner
Severance strength: World-class hospital ranked by Newsweek, with 30,000+ ablation procedures and deep clinical expertise
๐ฃ๏ธ Leadership Quotes
“This partnership will strengthen the clinical value of AI in cardiac care and help save lives.”
– Panki Kim, Co-CEO, Phantomics
“We’re excited to combine our clinical depth with Phantomics' technology to improve early detection and outcomes.”
– Dr. Seok Min Kang, Director, Severance Cardiovascular Hospital
Related the Article : Phantomics, Severance Hospital Partner to Combat Cardiovascular Disease with AI